NEW YORK (GenomeWeb News) – Researchers from the National Cancer Institute have sequenced the protein-coding portions of the NCI-60 human cancer cell line genomes, using the data to look for genetic contributors to drug response in the well-characterized cell line panel.

As they reported online today in Cancer Research, the researchers initially used whole-exome sequence data for the 60 cancer cell lines to put together a list of mutations suspected of being cancer-specific.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.